Yonsa
Payments companies reported to CMS as associated with Yonsa. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Yonsa, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Yonsa
These are the largest totals companies reported as associated with Yonsa. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Raoul Concepcion | Nashville, TN | Urology | $79,903.98 |
| Jose De La Cerda | San Antonio, TX | Urology | $33,756.87 |
| Paul Dato | La Mesa, CA | Urology | $32,133.12 |
| Bryan Mehlhaff | Springfield, OR | Urology | $28,223.36 |
| Christopher Pieczonka | Syracuse, NY | Urology | $15,366.19 |
| Sanjaykumar Hapani | Edmond, OK | Hematology & Oncology | $14,620.00 |
| Gautam Jayram | Nashville, TN | Urology | $11,551.53 |
| Antonio Fojo | New York, NY | Medical Oncology | $6,798.96 |
| Nashat Gabrail | Canton, OH | $6,606.86 | |
| Philip Philip | Detroit, MI | Medical Oncology | $5,557.11 |
Prescribed Yonsa?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.